Seretide Settlement To Lift Glenmark’s Europe Business

 
• By Anju Ghangurde

Glenmark can sell its partnered generic rival to GSK’s Seretide Accuhaler dry powder inhaler in certain European markets following a settlement with the UK company. The Indian firm has also shelved divestment plans for its API business, at least for now.

Asthma
Glenmark-Celon Can Launch Gx Seretide Accuhaler In Certain Markets • Source: Shutterstock

More from Business

More from Scrip